Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smartwatch track how kids recover from cancer surgery?

NCT ID NCT06674811

First seen Jan 28, 2026 · Last updated Jun 19, 2026 · Updated 26 times

Summary

This study is testing whether smartwatches and blood tests can measure how well children recover after surgery to remove a solid tumor. About 40 children and their caregivers will wear smartwatches and answer questionnaires before surgery and for up to a year after. Researchers will also look at proteins and metabolites in the blood to find patterns linked to recovery. The goal is to better understand surgical resilience and find ways to improve recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARCOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55901, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors better predict and support recovery after major cancer surgery in children.

What could go wrong

This is a small pilot study (40 participants) focused on measuring recovery, not testing a treatment. Results may not apply to all children or lead to immediate changes in care.

Conditions

The condition(s) this trial relates to.

neoplasm neuroblastoma sarcoma Wilms tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.